Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127409741 | 12740974 | 1 | I | 20160524 | 20160913 | 20160914 | 20160914 | EXP | CN-ROCHE-1829969 | ROCHE | 59.96 | YR | F | Y | 60.00000 | KG | 20160914 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127409741 | 12740974 | 1 | PS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | Y | SH6167 | 63239 | 2 | G | POWDER FOR INJECTION | QD | |||||
| 127409741 | 12740974 | 2 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous drip | SOLVENT | C16040505 | 0 | 100 | ML | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127409741 | 12740974 | 1 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127409741 | 12740974 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127409741 | 12740974 | Cyanosis | |
| 127409741 | 12740974 | Dizziness | |
| 127409741 | 12740974 | Lower respiratory tract congestion | |
| 127409741 | 12740974 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127409741 | 12740974 | 1 | 20160524 | 20160524 | 0 | |
| 127409741 | 12740974 | 2 | 20160524 | 20160524 | 0 |